News & Trends - Pharmaceuticals
Pharmacies gear up for surge in demand with COVID-19 + flu shot programs landing at same time

Pharma News: Pharmacists are preparing for another busy year ahead with the roll-out of COVID-19 vaccines and growing flu vaccination demand which this year will culminate at the same time.
According to a MedAdvisor survey of nearly 250 pharmacies, 97% of them will be providing the flu shot vaccine in store this year. A further 92% are looking to offer the COVID-19 vaccine this year with the majority citing that
the main driver behind offering the service is to help their communities overcome the virus rather than boost revenue.
“Last year, when the pandemic reached Australia, we were inundated with customers filling prescriptions, stocking up on pharmacy supplies and asking for COVID-19 related health advice. On top of that, we vaccinated
double the amount of patients against the flu compared to 2019.” George
Stefanos, proprietor and pharmacist from Amcal Mordialloc said.
“This year we expect to experience similar levels of consumer demand, with the addition of the COVID-19 vaccine which will coincide with flu season. Ahead of the vaccine rollout, we’re looking at how we can improve
our systems – leveraging technology, such as MedAdvisor which plays an
instrumental role in our pharmacy workflows to, ultimately, create a
better and more streamlined customer experience, either in-store or online.”
Last year, pharmacists dealt with dramatic patient increases with MedAdvisor flu shot data showing a 330% year-on-year spike in flu shots as Australians rushed to get immunised earlier than usual. Flu shot demand typically peaks in May. Last year, as a direct result of COVID-19, MedAdvisor saw that peak come forward with more people opting for the jab in April.
“Pharmacy is already doing a great job administering the flu shot each season. This year, the flu shot season will align with the roll-out of COVID-19 vaccines in pharmacies – which means having a system in place to streamline the patient experience is more important than ever,” MedAdvisor CEO Robert Read said.
MedAdvisor continues to develop its end-to-end pharmacy platform including booking functionality, in-app payment and medication delivery to help with the roll-out of COVID-19 and influenza vaccines as well as heightened consumer demand.
Earlier this month, Health Minister Greg Hunt announced a $200 million program to distribute the COVID-19 vaccine through pharmacies as part of the stage two roll-out.
Pharmacies in major cities will be paid up to $42 per person – $16 per jab, and $10 after the second vaccination – while the vaccine itself will be provided free of charge. In rural and regional areas the payment will be $48 per person.
The Federal Government will pay some of the 5,800 community pharmacies across the country who meet certain criteria to give coronavirus vaccines for free. The program is expected to start in May, when phase 2 of the rollout to people over 50 and Aboriginal and Torres Strait Islanders is due to start.
Leadership & Management

New Medicines Australia Chair critical to HTA reforms
Former MTPConnect Chair, Sue MacLeman, is taking the reins as Chair of Medicines Australia, bringing three decades of firepower in […]
MoreNews & Trends - Pharmaceuticals

PBS will never be subject to negotiation: Albanese rejects US pharma pressure at APP
Prime Minister Anthony Albanese has drawn a firm line in the sand, declaring that Australia’s Pharmaceutical Benefits Scheme (PBS) “will […]
MoreNews & Trends - MedTech & Diagnostics

Device implant to challenge weekly obesity injections in first Australian trial
Days following the announcement of the spin-off of its neurostimulation business to sharpen its focus on weight loss, obesity and […]
MoreNews & Trends - Pharmaceuticals

30% of IBD patients disconnected from clinicians: Professor Susie Connor
One in three Australians with inflammatory bowel disease (IBD) are leaving their medical appointments with critical misunderstandings about their condition […]
More